ClinicalTrials | Financial Buzz

Biotechnology Breaking News Healthcare Investing News Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Affimed N.V (NASDAQ: AFMD) Announces Positive Initial Clinical Data

financial buzz04/09/2021

2165

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Affimed N.V Announces Positive Initial Clinical Data” Affimed N.V. (NASDAQ: AFMD) surged over 30% in premarket trading after...

Breaking News Buzz On The Street Cannabis Buzz Healthcare Market News Medical Use Pharmaceutical Products Technology The Buzz TV The Market Buzz Top Videos Video

“Buzz on the Street” Show: HempFusion Wellness (OTCQX: CBDHF) (TSX: CBD.U) Completes Pilot Study

financial buzz03/29/202104/13/2021

5735

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “HempFusion Completes Inflammatory Markers Pilot Trial, Releases White Paper” HempFusion Wellness Inc. (OTCQX: CBDHF) (TSX: CBD.U),...

Breaking News Cannabis Buzz Investing News Market News Pharmaceutical Products Recreational Use The Market Buzz

Breaking News: HempFusion Completes Inflammatory Markers Pilot Trial, Releases White Paper

financial buzz03/25/2021

4239

HempFusion Wellness Inc. (OTCQX:CBDHF) (TSX: CBD.U) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce it...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

AstraZeneca Vaccine Proves to be 79% Effective in U.S. Trial

Rebecca Urena03/22/2021

2139

A U.S. trial found that AstraZeneca (OTCMKTS: AZNCF) and the University of Oxford’s coronavirus vaccine was 79% effective in preventing the covid-19 virus. Furthermore the vaccine is 100% effective...

Biotechnology Breaking News Buzz On The Street Healthcare Investing News Market News Technology The Buzz TV The Market Buzz Top Videos Video

“Buzz on the Street” Show: Mydecine Innovations (OTC: MYCOF) (CSE: MYCO) Export of Psilocybin

financial buzz03/01/202103/04/2021

5066

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Mydecine Fully Completes the First-Ever International Export of Psilocybin Mushrooms and Solidifies its Clinical and Commercial...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Market Buzz

Breaking News: Mydecine Fully Completes the First-Ever International Export of Psilocybin Mushrooms and Solidifies its Clinical and Commercial Supply Chain

financial buzz03/01/202103/01/2021

10091

Mydecine Innovations Group (OTC: MYCOF) (CSE: MYCO) (FSE: 0NFA) (“Mydecine” or the “Company’), an emerging biopharma company in the life sciences category committed to the research and development, production,...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Johnson & Johnson Files for Emergency Use Authorization

Rebecca Urena02/05/2021

3322

Johnson and Johnson (NYSE: JNJ) has requested emergency use authorization from the Food and Drug Administration for its single-dose COVID19 vaccine. The company recently shared data demonstrating its vaccine...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Sorrento Therapeutics (NASDAQ: SRNE) Reports Positive Results from COVI-MSC Study

Bryan Shin01/27/2021

2208

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Sorrento Therapeutics Reports Positive Results from COVI-MSC Study Sorrento Therapeutics (NASDAQ: SRNE) rose 28% by midday after the...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical The Market Buzz Your Environment

Moderna Set to Test Covid-19 Booster Shoots

Rebecca Urena01/15/202101/15/2021

2424

Moderna (NASDAQ: MRNA) revealed it plans to test a booster shot for its COVID-19 vaccine a year after executing the two-dose immunization as it is unclear how long the...

Biotechnology Breaking News Healthcare Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Arcturus Therapeutics (NASDAQ: ARCT) Shares Fall After Analyst Downgrade Stock

financial buzz12/29/202012/29/2020

2174

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Arcturus Therapeutics Shares Fall After Analyst Downgrade Stock” Arcturus Therapeutics (NASDAQ: ARCT) plunged over 41% after analysts downgraded...

Tag: ClinicalTrials